HomeINTI • OTCMKTS
add
Inhibitor Therapeutics Inc
Previous close
$0.049
Day range
$0.049 - $0.060
Year range
$0.040 - $0.14
Market cap
10.09M USD
Avg Volume
26.56K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.48M | 16.57% |
Net income | -1.42M | -21.81% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.61M | -36.57% |
Total assets | 5.69M | -36.37% |
Total liabilities | 3.71M | 1.21% |
Total equity | 1.99M | — |
Shares outstanding | 172.32M | — |
Price to book | 4.91 | — |
Return on assets | -61.10% | — |
Return on capital | -137.64% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.42M | -21.81% |
Cash from operations | -771.44K | -10.57% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -771.44K | -10.57% |
Free cash flow | -277.25K | 15.02% |
About
Founded
1992
Headquarters
Website
Employees
6
